Risk Factors Update Summary

• Increased penalties under the federal Civil False Claims Act, with fines ranging from $13,500 to $27,894 per false claim.
• History of losses and future profitability uncertainty raised substantial doubt regarding continuing as a going concern.
• Potential impact from changes to the ACA, including the extension of premium tax credits through 2025.
• Net losses increased from $240.3 million to $377 million, impacting future profitability and financial stability.
• Decrease in Medicare payments to physicians by nearly 3.4% in 2024, affecting reimbursement for services.
• Outstanding indebtedness increased from $240.3 million to $377 million, affecting growth prospects and financial condition.
• Implementation of penalties for information blocking post-September 1, 2023, under the 21st Century Cures Act.
• Reverse stock split on January 31, 2024, at a ratio of 1-for-30 shares, impacting outstanding shares.
• Potential delisting from the Nasdaq Global Select Market due to non-compliance with minimum bid price requirements.
• Dilution risk from the issuance of Earnout Shares and warrants, impacting the number of outstanding shares.